Indian patients now have access to a new once-weekly insulin alternative. This drug offers a significant reduction in injections from daily to just 52 days annually. Doctors see this as an expansion of treatment options rather than a complete replacement. The weekly insulin is best suited for specific patients requiring basal insulin replacement. While an important advance, other diabetes treatments are also reducing insulin needs.
Be the first to comment